192 related articles for article (PubMed ID: 1398287)
21. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
23. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
24. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas.
Lehtinen T; Aine R; Lehtinen M; Kallioniemi OP; Leino T; Hakala T; Leinikki P; Alavaikko M
J Pathol; 1989 Jan; 157(1):27-36. PubMed ID: 2921665
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.
Young GA; Hedley DW; Rugg CA; Iland HJ
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1497-504. PubMed ID: 3678313
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
Wu HM
J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
[TBL] [Abstract][Full Text] [Related]
30. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Joensuu H; Klemi PJ; Jalkanen S
Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
[TBL] [Abstract][Full Text] [Related]
32. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
Alanen KA; Joensuu H; Klemi PJ
Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
[TBL] [Abstract][Full Text] [Related]
33. Determination of DNA ploidy in archival tissue from non-Hodgkin's lymphoma using flow and image cytometry.
Zbieranowski I; Le Riche JC; Palcic B; Gascoyne R; Connors J
Anal Cell Pathol; 1992 Jul; 4(4):303-13. PubMed ID: 1390299
[TBL] [Abstract][Full Text] [Related]
34. Comparison between image and flow DNA cytometry in non-Hodgkin's lymphomas.
Felman P; French M; Souchier C; Magaud JP; Gentilhomme O; Bryon PA
Pathol Res Pract; 1989 Nov; 185(5):709-14. PubMed ID: 2626380
[TBL] [Abstract][Full Text] [Related]
35. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
Winter JN; Andersen J; Variakojis D; Gordon LI; Fisher RI; Oken MM; Neiman RS; Jiang S; Bauer KD
Blood; 1996 Nov; 88(10):3919-25. PubMed ID: 8916958
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
38. DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.
Erdkamp FL; Breed WP; Schouten HC; Janssen WC; Hoffmann JJ; Wijnen JT; Blijham GH
Ann Oncol; 1993 Jan; 4(1):75-80. PubMed ID: 8435368
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic significance of flow cytophotometric studies in ovarian cancer].
Volm M; Kleine W
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):456-9. PubMed ID: 3623048
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of cell proliferation in major salivary gland carcinomas.
Suzzi MV; Alessi A; Bertarelli C; Cancellieri A; Procaccio L; Dall'olio D; Laudadio P
Acta Otorhinolaryngol Ital; 2005 Jun; 25(3):161-8. PubMed ID: 16450771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
